urlscan.io logo urlscan.io
SecurityTrails logo

www.mdalert.com Open in urlscan Pro
2606:4700:3032::681b:9282  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: http://emsg.alertmarketingmail.com/t?r=6226&c=917822&l=31794&ctl=587D4:29E3D51F0A7DD25EAF69FB90A41F229D3B7A44FE04F1CD0C&utm_content...
Effective URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_s...
Submission: On October 10 via manual from US
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 19 IPs in 5 countries across 19 domains to perform 66 HTTP transactions. The main IP is 2606:4700:3032::681b:9282, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.mdalert.com.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 6th 2020. Valid for: a year.
This is the only time www.mdalert.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

1    34.210.132.119 (Boardman, United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-210-132-119.us-west-2.compute.amazonaws.com
emsg.alertmarketingmail.com
17    2606:4700:3032::681b:9282 (United States)

ASN13335 (CLOUDFLARENET, US)
www.mdalert.com
1    2a00:1450:4001:824::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
fonts.googleapis.com
2    2a02:26f0:eb:391::1e80 (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
assets.adobedtm.com
8    2600:9000:206e:8c00:3:c04e:c780:93a1 (United States)

ASN16509 (AMAZON-02, US)
ws.sharethis.com
1    65.9.96.7 (Seattle, United States)

ASN16509 (AMAZON-02, US)
consent.trustarc.com
1    2a00:1450:4001:816::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
fonts.gstatic.com
5    54.86.143.179 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-86-143-179.compute-1.amazonaws.com
ads.ehealthcaresolutions.com
1    2600:9000:2127:b800:c:a9b7:ddc0:93a1 (United States)

ASN16509 (AMAZON-02, US)
c.sharethis.mgr.consensu.org
2    18.195.43.194 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-195-43-194.eu-central-1.compute.amazonaws.com
l.sharethis.com
2    34.242.67.216 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-242-67-216.eu-west-1.compute.amazonaws.com
dpm.demdex.net
1    52.213.60.94 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-213-60-94.eu-west-1.compute.amazonaws.com
mdalert.demdex.net
5    15.236.9.100 (Paris, France)

ASN16509 (AMAZON-02, US)
PTR: ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
mdalert.sc.omtrdc.net
1    66.117.28.86 (United States)

ASN15224 (OMNITURE, US)
cm.everesttech.net
4    2a00:1450:4001:819::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google-analytics.com
1    2606:4700:3035::681b:8e4b (United States)

ASN13335 (CLOUDFLARENET, US)
ads.jobson.com
3    2a00:1450:4001:808::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagservices.com
adservice.google.de
adservice.google.com
6    172.217.22.98 (United States)

ASN15169 (GOOGLE, US)
PTR: fra15s18-in-f98.1e100.net
securepubads.g.doubleclick.net
1    2a00:1450:4001:824::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
24783b95da8401f8f3739b9a78e012d7.safeframe.googlesyndication.com
3    2a00:1450:4001:806::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
tpc.googlesyndication.com
2    2a00:1450:4001:81a::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
pagead2.googlesyndication.com
Domain Requested by
17 www.mdalert.com www.mdalert.com
8 ws.sharethis.com www.mdalert.com
ws.sharethis.com
6 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
5 mdalert.sc.omtrdc.net assets.adobedtm.com
www.mdalert.com
5 ads.ehealthcaresolutions.com www.mdalert.com
4 www.google-analytics.com www.mdalert.com
www.google-analytics.com
3 tpc.googlesyndication.com securepubads.g.doubleclick.net
tpc.googlesyndication.com
2 pagead2.googlesyndication.com securepubads.g.doubleclick.net
2 dpm.demdex.net assets.adobedtm.com
www.mdalert.com
2 l.sharethis.com ws.sharethis.com
www.mdalert.com
2 assets.adobedtm.com www.mdalert.com
assets.adobedtm.com
1 24783b95da8401f8f3739b9a78e012d7.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 adservice.google.com securepubads.g.doubleclick.net
1 adservice.google.de securepubads.g.doubleclick.net
1 www.googletagservices.com ads.ehealthcaresolutions.com
1 ads.jobson.com www.mdalert.com
1 cm.everesttech.net 1 redirects
1 mdalert.demdex.net assets.adobedtm.com
1 c.sharethis.mgr.consensu.org ws.sharethis.com
1 fonts.gstatic.com fonts.googleapis.com
1 consent.trustarc.com www.mdalert.com
1 fonts.googleapis.com www.mdalert.com
1 emsg.alertmarketingmail.com 1 redirects
66 23

This site contains links to these domains. Also see Links.

Domain
pdfcrowd.com
www.jobson.com
submit-irm.trustarc.com
facebook.com
twitter.com
www.linkedin.com
Subject Issuer Validity Valid
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3		 2020-07-06 -
2021-07-06		 a year crt.sh
upload.video.google.com
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh
assets.adobedtm.com
DigiCert SHA2 High Assurance Server CA		 2019-10-22 -
2021-10-01		 2 years crt.sh
sharethis.com
Amazon		 2020-08-17 -
2021-09-16		 a year crt.sh
*.trustarc.com
Go Daddy Secure Certificate Authority - G2		 2020-05-21 -
2022-07-17		 2 years crt.sh
*.gstatic.com
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh
*.ehealthcaresolutions.com
Go Daddy Secure Certificate Authority - G2		 2019-08-11 -
2020-10-10		 a year crt.sh
sharethis.mgr.consensu.org
Amazon		 2020-05-05 -
2021-06-05		 a year crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA		 2018-01-09 -
2021-02-12		 3 years crt.sh
*.sc.omtrdc.net
DigiCert SHA2 High Assurance Server CA		 2020-02-28 -
2022-03-04		 2 years crt.sh
*.google-analytics.com
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh
*.g.doubleclick.net
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh
*.google.com
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1		 2020-09-22 -
2020-12-15		 3 months crt.sh

This page contains 5 frames:

Primary Page: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Frame ID: 0ECB5CCEDC487720423342F575AC872F
Requests: 62 HTTP requests in this frame

Frame: https://c.sharethis.mgr.consensu.org/portal-v2.html
Frame ID: A559C982A5B903D7364B835F4E9B5DEE
Requests: 1 HTTP requests in this frame

Frame: https://mdalert.demdex.net/dest5.html?d_nsid=0
Frame ID: 6B1E63A16FF88285E3D16F6F213299A5
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/217/runner.html
Frame ID: B785ADB95CB811430E32B4F0B31AB923
Requests: 1 HTTP requests in this frame

Frame: https://ws.sharethis.com/secure5x/index.html
Frame ID: 052CE789E8579C1028C3181DF96467A9
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. http://emsg.alertmarketingmail.com/t?r=6226&c=917822&l=31794&ctl=587D4:29E3D51F0A7DD25EAF69FB90A41F229D3B7A44FE... HTTP 302
    https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • script /\/\/assets.adobedtm.com\//i
Overall confidence: 100%
Detected patterns
  • headers server /^cloudflare$/i
Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i
Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i
Overall confidence: 100%
Detected patterns
  • html /<link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com/i

Page Statistics

66
Requests

100 %
HTTPS

57 %
IPv6

19
Domains

23
Subdomains

19
IPs

5
Countries

428 kB
Transfer

1270 kB
Size

21
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://emsg.alertmarketingmail.com/t?r=6226&c=917822&l=31794&ctl=587D4:29E3D51F0A7DD25EAF69FB90A41F229D3B7A44FE04F1CD0C&utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149 HTTP 302
    https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://cm.everesttech.net/cm/dd?d_uuid=82891840443463937234128117664307885371 HTTP 302
  • https://dpm.demdex.net/ibs:dpid=411&dpuuid=X4GR-AAAB96m7BTJ

66 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
Primary Request fda-grants-priority-review-evinacumab
www.mdalert.com/ms/hyperlipidemia/article/
Redirect Chain
  • http://emsg.alertmarketingmail.com/t?r=6226&c=917822&l=31794&ctl=587D4:29E3D51F0A7DD25EAF69FB90A41F229D3B7A44FE04F1CD0C&utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyp...
  • https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21A...
30 KB
8 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e7c3ff35188e2eeffeb1c0cee45682026b81e0443f006b48c5c54956a762bf84

Request headers

:method
GET
:authority
www.mdalert.com
:scheme
https
:path
/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
date
Sat, 10 Oct 2020 10:50:35 GMT
content-type
text/html; charset=utf-8
set-cookie
__cfduid=d9513a5e0deea2362a1ab54715c10f45b1602327035; expires=Mon, 09-Nov-20 10:50:35 GMT; path=/; domain=.mdalert.com; HttpOnly; SameSite=Lax; Secure ASP.NET_SessionId=lmjjkjv4b1r4qzmdtfhz4cuk; path=/; HttpOnly; SameSite=Lax ASP.NET_SessionId=lmjjkjv4b1r4qzmdtfhz4cuk; path=/; HttpOnly; SameSite=Lax mda_hyperlipidemia_seg=; path=/ mduid=C787CF24DE0EE21AFA8D5BB76C36E25A; expires=Mon, 09-Nov-2020 11:50:35 GMT; path=/ uid_npi=1023182227; expires=Mon, 09-Nov-2020 11:50:35 GMT; path=/ BIGipServerjhi-pharm-job-23.portal.webmd.com-80=4244643082.20480.0000; path=/; Httponly
cache-control
private
vary
Accept-Encoding
cf-cache-status
DYNAMIC
cf-request-id
05b3bb552600001f55c7afa200000001
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
nel
{"report_to":"cf-nel","max_age":604800}
server
cloudflare
cf-ray
5dffc801da241f55-FRA
content-encoding
br

Redirect headers

Server
Apache-Coyote/1.1
Location
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Content-Type
text/html;charset=UTF-8
Content-Length
0
Date
Sat, 10 Oct 2020 10:50:34 GMT
css
fonts.googleapis.com/ 		4 KB
701 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://fonts.googleapis.com/css?family=Roboto+Slab:400,700
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
bd5c5bda6df214f9c6bfa5271c264bb6f4a9672e7f168ddf95972267b2a69bcd
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Sat, 10 Oct 2020 10:16:20 GMT
server
ESF
date
Sat, 10 Oct 2020 10:50:35 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Sat, 10 Oct 2020 10:50:35 GMT
css
www.mdalert.com/Content/ 		139 KB
22 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/Content/css?v=7g0mgopDnjlNDFJFw634pzPXUZ7qBKcVEtSiyw-6svE1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
351bd29496a9df65da3f99da8a6c3c6654f31ab50a67f4c859467ea6797fa66a

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:35 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/css; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8041f301f55-FRA
cf-request-id
05b3bb569200001f55c7b3c200000001
expires
Sun, 10 Oct 2021 10:50:35 GMT
modernizr
www.mdalert.com/bundles/ 		11 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/modernizr?v=inCVuEFe6J4Q07A0AcRsbJic_UE5MwpRMNGcOtk94TE1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9e83216908224ffbc39992a5e60f93ca21b8e2240ba28025ba679c4b70f7112d

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:35 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8041f311f55-FRA
cf-request-id
05b3bb569200001f55c7b3d200000001
expires
Sun, 10 Oct 2021 10:50:35 GMT
launch-4f529be4e422.min.js
assets.adobedtm.com/4928ad52470e/46c35e8b30ec/ 		173 KB
44 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb:391::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
35972e0b5d83fae287874f40c92c94598b1eb522d8229d48b00efad5b3840805

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
gzip
last-modified
Tue, 01 Sep 2020 18:52:38 GMT
server
AkamaiNetStorage
status
200
etag
"75ebe3bcce15df983693701a67482377:1598986358.629174"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
https://www.mdalert.com
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 10 Oct 2020 11:50:35 GMT
AdobeEngagementTracking.js
www.mdalert.com/tracking/ 		6 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/tracking/AdobeEngagementTracking.js?v=1.4
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
719fc961628dfc504a8d29920ba1dbeb1703730b4101b14dac3cd8228c4a106b

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Fri, 15 May 2020 13:23:53 GMT
server
cloudflare
etag
W/"c3de5014bc2ad61:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
status
200
cache-control
max-age=14400
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8041f321f55-FRA
cf-request-id
05b3bb569200001f55c7b3e200000001
_adobeEvents.js
www.mdalert.com/Scripts/ 		794 B
515 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/Scripts/_adobeEvents.js?v=2
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
de905bc976ff56ee7cbcbc680194b2da8c74ebe227f16ef7333daa92e3e864bc

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Thu, 01 Mar 2018 20:52:25 GMT
server
cloudflare
etag
W/"f093a349fb1d31:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
status
200
cache-control
max-age=14400
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8041f341f55-FRA
cf-request-id
05b3bb569200001f55c7b3f200000001
jquery
www.mdalert.com/bundles/ 		85 KB
30 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/jquery?v=Qt6CTo-CvS3Lv6WgwGVOU8ElJMZ6SHbe8iwHiqQ8m-41
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e748e8544be5e7ba658d59b3463ea9770df8aab091c9d94e980e67df51886148

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:35 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8041f351f55-FRA
cf-request-id
05b3bb569200001f55c7b40200000001
expires
Sun, 10 Oct 2021 10:50:35 GMT
buttons.js
ws.sharethis.com/button/ 		58 KB
16 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ws.sharethis.com/button/buttons.js
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
71d716f10f708487400cb56962eac2fbac08ec1c471198acd9c2e2498d2544f0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 08 Oct 2020 18:53:21 GMT
content-encoding
gzip
server
nginx/1.16.1
age
143834
etag
"5f777247-e713"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=259200
x-amz-cf-pop
VIE50-C1
x-robots-tag
noindex, nofollow
x-amz-cf-id
RmDDC0Zicd8OKO5T4y_4BbEFSJsDSwD15kGYd0S8rRxJrIB-7Cnyhw==
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
expires
Sun, 11 Oct 2020 18:53:21 GMT
logo-mdalert-full.png
www.mdalert.com/images/ 		6 KB
6 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/images/logo-mdalert-full.png
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fbf09f304118a296d4ee00fd5aaea39280659fd9c8b143ed5255760e2595965d

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
MISS
nel
{"report_to":"cf-nel","max_age":604800}
status
200
content-length
6152
cf-request-id
05b3bb57fa00001f55c7b5f200000001
last-modified
Mon, 21 Dec 2015 21:01:40 GMT
server
cloudflare
etag
"494ecfc9323cd11:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
max-age=14400
accept-ranges
bytes
cf-ray
5dffc8065c131f55-FRA
hyperlipid-1-cropped.jpg
www.mdalert.com/CMSImagesContent/2020/09/CH/ 		18 KB
19 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/CMSImagesContent/2020/09/CH/hyperlipid-1-cropped.jpg
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0ddee1dbf24b12e6c336965a7ee26a00341fb8be675cab045ec8ebb9d3a8f09d

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
MISS
nel
{"report_to":"cf-nel","max_age":604800}
status
200
content-length
18893
cf-request-id
05b3bb57fb00001f55c7b60200000001
last-modified
Fri, 11 Sep 2020 17:19:01 GMT
server
cloudflare
etag
"30133fa45f88d61:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/jpeg
cache-control
max-age=259200
accept-ranges
bytes
cf-ray
5dffc8065c151f55-FRA
subscribe
www.mdalert.com/ 		43 B
414 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/subscribe?uid=C787CF24DE0EE21AFA8D5BB76C36E25A&mid=hyperlipidemia
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
98b3d9d20e032f90aca49e9b116225d539ff6fbdb7e42c3c363f63896ac03d2a

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
DYNAMIC
nel
{"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/gif
status
200
cache-control
no-cache, no-store
cf-ray
5dffc8065c161f55-FRA
content-length
43
cf-request-id
05b3bb57fb00001f55c7b61200000001
expires
-1
notice
consent.trustarc.com/ 		1 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://consent.trustarc.com/notice?domain=jobson.com&c=teconsent&js=nj&noticeType=bb&text=true&cookieLink=https%3A%2F%2Fwww.jobson.com%2Fpolicies%2Fca-privacy-policy-jhi.pdf&privacypolicylink=https%3A%2F%2Fwww.jobson.com%2Fpolicies%2Fprivacy-policy-jhi-subsidiaries-cme.pdf
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.96.7 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx /
Resource Hash
bfabf982c85e694514e71aabf5e253b51ebfd034441d9bbff725f68ba0b2ab2c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-amz-cf-pop
PRG50-C1
x-cache
Miss from cloudfront
status
200
content-length
651
x-xss-protection
1; mode=block
access-control-allow-origin
*
server
nginx
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/javascript;charset=UTF-8
via
1.1 91afcef6d5c7e90d0a4bb2c3a456c691.cloudfront.net (CloudFront)
cache-control
no-cache
x-amz-cf-id
nw1hPPt63PNfJeXRLpOTRGN05OVA7NEcEWaZ8tixPeH5RUYp2Gsg3A==
expires
Sat, 10 Oct 2020 10:50:35 GMT
icon-facebook-sm.png
www.mdalert.com/images/ 		933 B
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/images/icon-facebook-sm.png
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d36cfcacdd5c7fcdce40cf35a23a1d79111f4924d9834aaea974aad05587c077

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
MISS
nel
{"report_to":"cf-nel","max_age":604800}
status
200
content-length
933
cf-request-id
05b3bb57fb00001f55c7b62200000001
last-modified
Mon, 05 Jan 2015 19:28:19 GMT
server
cloudflare
etag
"f91128c31d29d01:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
max-age=14400
accept-ranges
bytes
cf-ray
5dffc8065c171f55-FRA
icon-twitter-sm.png
www.mdalert.com/images/ 		1 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/images/icon-twitter-sm.png
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3e760a0b3d9f13e4717a31c8bfdf5229a3184c592e2b51b5b24a9b56b5376f29

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
MISS
nel
{"report_to":"cf-nel","max_age":604800}
status
200
content-length
1422
cf-request-id
05b3bb57fb00001f55c7b63200000001
last-modified
Mon, 05 Jan 2015 19:28:41 GMT
server
cloudflare
etag
"9be2cd01d29d01:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
max-age=14400
accept-ranges
bytes
cf-ray
5dffc8065c181f55-FRA
icon-linkedin-sm.png
www.mdalert.com/images/ 		1 KB
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.mdalert.com/images/icon-linkedin-sm.png
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5bc478e4b7ac20ab77112eb0b8ca65b0b39e41af625bb106384027b66c8e9729

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
cf-cache-status
MISS
nel
{"report_to":"cf-nel","max_age":604800}
status
200
content-length
1393
cf-request-id
05b3bb57fb00001f55c7b64200000001
last-modified
Mon, 05 Jan 2015 19:28:57 GMT
server
cloudflare
etag
"59b4aad91d29d01:0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
image/png
cache-control
max-age=14400
accept-ranges
bytes
cf-ray
5dffc8065c1b1f55-FRA
bootstrap
www.mdalert.com/bundles/ 		62 KB
17 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/bootstrap?v=we9t4tj3gJ1fzSLEEVDKtp9ofnchBKezsnrGBj5Cgrw1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
67c8e0ae7b51850b7c5b462fe8432628c0203da08e91da6b3bb7f4b81c3a282d

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:35 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc805fb2b1f55-FRA
cf-request-id
05b3bb57be00001f55c7b57200000001
expires
Sun, 10 Oct 2021 10:50:35 GMT
search
www.mdalert.com/bundles/ 		975 B
530 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/search?v=k1AfDNk5spqSKfs9BNxpKRhevp8sy5ozaZ8djuZBZeA1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
73543157fb739b22705f544ba59d686f66e41f28020df5a5e1a5adf1eccfe9a6

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:35 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:35 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc805fb301f55-FRA
cf-request-id
05b3bb57be00001f55c7b58200000001
expires
Sun, 10 Oct 2021 10:50:35 GMT
handlebars
www.mdalert.com/bundles/ 		63 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/handlebars?v=xYnYyRegeB-HBh8tJCpHd1twAZoKhEmZCOL3SgmeS4c1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1b08bc9792496d6b72a853a44a612bfe6c878b23fcc86f940afc882b57eb4e3c

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:36 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8065c0f1f55-FRA
cf-request-id
05b3bb57fa00001f55c7b5c200000001
expires
Sun, 10 Oct 2021 10:50:36 GMT
site
www.mdalert.com/bundles/ 		2 KB
774 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/site?v=Z91SZrTl0oedzeXRiEvU0XlBkZn7KwmoObumI1-7TJ01
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
82b4eefc3ad12ab4c7292da58b7c7ff378cd60e0162aa048ec58a053fc74cb24

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:36 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8065c111f55-FRA
cf-request-id
05b3bb57fa00001f55c7b5d200000001
expires
Sun, 10 Oct 2021 10:50:36 GMT
cms-article-modal
www.mdalert.com/bundles/ 		240 B
291 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.mdalert.com/bundles/cms-article-modal?v=eszX79aflkiZb1_p-oRvgRSbZ9LXMhIslP2XJ6KzkQc1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3032::681b:9282 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5142a745d8893c73a803a6e6cc47bc80d3dbcab4816a76e7c512407b69583dc9

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
cf-cache-status
DYNAMIC
last-modified
Sat, 10 Oct 2020 10:50:36 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
User-Agent,Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript; charset=utf-8
status
200
cache-control
public
nel
{"report_to":"cf-nel","max_age":604800}
cf-ray
5dffc8065c121f55-FRA
cf-request-id
05b3bb57fa00001f55c7b5e200000001
expires
Sun, 10 Oct 2021 10:50:36 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v12/ 		30 KB
30 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/robotoslab/v12/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Roboto+Slab:400,700
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a0e89bf9070896e8016be5d04a290635ea0a95e9c8bc6dbfcd3ee45bc41fc5a0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.mdalert.com
Referer
https://fonts.googleapis.com/css?family=Roboto+Slab:400,700
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sun, 04 Oct 2020 09:47:33 GMT
x-content-type-options
nosniff
last-modified
Fri, 26 Jun 2020 02:33:54 GMT
server
sffe
age
522182
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
30940
x-xss-protection
0
expires
Mon, 04 Oct 2021 09:47:33 GMT
async-buttons.js
ws.sharethis.com/button/ 		89 KB
19 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ws.sharethis.com/button/async-buttons.js
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
b80a71bbfd599367ed06d6cd8a59d87bf0b02aafde9b20b1554abcfbf00abae3

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 09 Oct 2020 09:08:40 GMT
content-encoding
gzip
server
nginx/1.16.1
age
92516
etag
W/"5f77729b-16245"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=259200
x-amz-cf-pop
VIE50-C1
x-robots-tag
noindex, nofollow
x-amz-cf-id
_bGtKH2h5HKs-tysZZashwHuFHAjPUFCN9_nQtgfZB_sw2gvsw-rPA==
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
expires
Mon, 12 Oct 2020 09:08:40 GMT
/
ads.ehealthcaresolutions.com/jobson/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-hd1&site=ehs.pro.jobson.mdalert&size=728x90&vpos=t&hpos=l&zone=hyperlipidemia&cat=&seg=&r=184954466426576.75&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.86.143.179 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-86-143-179.compute-1.amazonaws.com
Software
Apache/2.4.27 (Ubuntu) /
Resource Hash
462a88b40127d3fece317465dface5403f301b04321f2d20d9ffe1be717fc4db

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
server
Apache/2.4.27 (Ubuntu)
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
status
200
cache-control
no-cache, must-revalidate
content-length
1738
/
ads.ehealthcaresolutions.com/jobson/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-rc1&site=ehs.pro.jobson.mdalert&size=300x250,300x600,160x600&vpos=t&hpos=r&zone=hyperlipidemia&cat=&seg=&r=2997895434716202.5&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.86.143.179 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-86-143-179.compute-1.amazonaws.com
Software
Apache/2.4.27 (Ubuntu) /
Resource Hash
ce98bbb72897e3ead7a69a944518ee63535411172cdbfd1bcd88f0dcf9929a1c

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
server
Apache/2.4.27 (Ubuntu)
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
status
200
cache-control
no-cache, must-revalidate
content-length
1747
/
ads.ehealthcaresolutions.com/jobson/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-rc2&site=ehs.pro.jobson.mdalert&size=300x250,300x600,160x600&vpos=t&hpos=r&zone=hyperlipidemia&cat=&seg=&r=8166080233895827&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.86.143.179 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-86-143-179.compute-1.amazonaws.com
Software
Apache/2.4.27 (Ubuntu) /
Resource Hash
8861f2b4a11c4427a277ab07bd16752e7b5e40466a0c559a8ebc401f74625867

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
server
Apache/2.4.27 (Ubuntu)
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
status
200
cache-control
no-cache, must-revalidate
content-length
1745
/
ads.ehealthcaresolutions.com/jobson/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-rc3&site=ehs.pro.jobson.mdalert&size=300x250,300x600,160x600&vpos=t&hpos=r&zone=hyperlipidemia&cat=&seg=&r=1805652023976116.5&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.86.143.179 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-86-143-179.compute-1.amazonaws.com
Software
Apache/2.4.27 (Ubuntu) /
Resource Hash
1a5ca8d641c0ccd7316a158577f200b60cc7c00a686809c203c88fbab81cd158

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
server
Apache/2.4.27 (Ubuntu)
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
status
200
cache-control
no-cache, must-revalidate
content-length
1746
/
ads.ehealthcaresolutions.com/jobson/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-rc4&site=ehs.pro.jobson.mdalert&size=300x250,300x600,160x600&vpos=t&hpos=r&zone=hyperlipidemia&cat=&seg=&r=895874397173206.4&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.86.143.179 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-86-143-179.compute-1.amazonaws.com
Software
Apache/2.4.27 (Ubuntu) /
Resource Hash
b5b5ef8f8f469980400ca0e4f0a289e34b9e79cb9dc08130a0ae8a2370191f7e

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
server
Apache/2.4.27 (Ubuntu)
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
status
200
cache-control
no-cache, must-revalidate
content-length
1746
portal-v2.html
c.sharethis.mgr.consensu.org/ Frame A559 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://c.sharethis.mgr.consensu.org/portal-v2.html
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2127:b800:c:a9b7:ddc0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
c.sharethis.mgr.consensu.org
:scheme
https
:path
/portal-v2.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149

Response headers

status
200
content-type
text/html; charset=utf-8
accept-ranges
bytes
content-encoding
gzip
last-modified
Thu, 01 Oct 2020 18:27:43 GMT
date
Sat, 10 Oct 2020 10:49:36 GMT
cache-control
max-age=3600, public
etag
W/"83a-174e56b8518"
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 e3568b144ae2b93deb0c17907b662ac2.cloudfront.net (CloudFront)
x-amz-cf-pop
PRG50-C1
x-amz-cf-id
IO9SDGD5Bjc--f_fhf-0PxlSyxsQ2yrFunY9JRC-2kreu2s-8dYjWQ==
age
59
pview
l.sharethis.com/ 		0
337 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://l.sharethis.com/pview?event=pview&version=buttons.js&lang=en&sessionID=1602327035891.74391&hostname=www.mdalert.com&location=%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&product=widget&fcmp=false&fcmpv2=false&publisher=f96e4750-7650-4314-8266-295613c9e1bf&bsamesite=true&consentDomain=.consensu.org&gdpr_domain=.consensu.org&gdpr_domain_v1=.consensu.org&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&title=FDA%20Grants%20Priority%20Review%20of%20Evinacumab%20BLA%20for%20High%20Cholesterol%20Condition%20-%20MDalert.com&sop=false&description=The%20FDA%20has%20granted%20priority%20review%20for%20a%20Biologics%20License%20Application%20for%20evinacumab%20as%20an%20adjunct%20treatment%20for%20patients%20with%20homozygous%20familial%20hypercholesteremia...
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.43.194 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-195-43-194.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Sat, 10 Oct 2020 10:50:36 GMT
Access-Control-Max-Age
1728000
Access-Control-Allow-Origin
https://www.mdalert.com
Access-Control-Expose-Headers
stid
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
id
dpm.demdex.net/ 		366 B
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://dpm.demdex.net/id?d_visid_ver=4.4.1&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=46BC515C56B0B1DD7F000101%40AdobeOrg&d_nsid=0&ts=1602327036022
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.242.67.216 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-242-67-216.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
d3b393e60cf19d535f7be30d53ef11ea97cb7331903b83b418ff6b7a3845c367
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v083-04df0ecd1.edge-irl1.demdex.com 5.78.1.20201008074624 3ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Encoding
gzip
X-TID
LyWP5EUcTOw=
Vary
Origin, Accept-Encoding, User-Agent
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.mdalert.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
304
Expires
Thu, 01 Jan 1970 00:00:00 GMT
EXc1938340c2e74c11b27385c8c581b857-libraryCode_source.min.js
assets.adobedtm.com/4928ad52470e/46c35e8b30ec/45d43c8224a4/ 		37 KB
14 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/45d43c8224a4/EXc1938340c2e74c11b27385c8c581b857-libraryCode_source.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb:391::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
1af270800c23fb9da6c31472a444ffcd6bf6d50704153427791e5361f825830d

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
last-modified
Tue, 01 Sep 2020 18:52:39 GMT
server
AkamaiNetStorage
status
200
etag
"51bef157292d80fc7c5f1cf6e342a079:1598986359.757857"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
https://www.mdalert.com
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
14113
expires
Sat, 10 Oct 2020 11:50:36 GMT
buttons-secure.css
ws.sharethis.com/button/css/ 		23 KB
4 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://ws.sharethis.com/button/css/buttons-secure.css
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/async-buttons.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
95dc1b83a7c030dd13ab3e29df921f10e04208b28734f172ea232854264c3b05

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 05:49:11 GMT
content-encoding
gzip
last-modified
Fri, 09 Oct 2020 19:01:02 GMT
server
nginx/1.16.1
age
18085
etag
W/"5f80b36e-5a76"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
x-amz-cf-pop
VIE50-C1
x-robots-tag
noindex, nofollow
content-length
3851
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
x-amz-cf-id
ulBCmTcv5mwn4B37gJr9v8vmj8RJWKJatlijrMLWTTK52IfQtVqtaQ==
facebook_16.png
ws.sharethis.com/images/2017/ 		514 B
867 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ws.sharethis.com/images/2017/facebook_16.png
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/css/buttons-secure.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
37d0b7ef0fb40b907a361462b2aa01144af114129d47af74c634343d44af214d

Request headers

Referer
https://ws.sharethis.com/button/css/buttons-secure.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 02 Oct 2020 18:53:22 GMT
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
server
nginx/1.16.1
age
662234
etag
"5f763ff3-202"
x-cache
Hit from cloudfront
content-type
image/png
status
200
cache-control
max-age=31536000
x-amz-cf-pop
VIE50-C1
accept-ranges
bytes
x-robots-tag
noindex, nofollow
content-length
514
x-amz-cf-id
Y_bE5vjXZA3dRYj7cSQnIS3qg9cYPVQE39DZbGH8FiD38fy4Q_aELw==
expires
Sat, 02 Oct 2021 18:53:22 GMT
twitter_16.png
ws.sharethis.com/images/2017/ 		845 B
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ws.sharethis.com/images/2017/twitter_16.png
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/css/buttons-secure.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
2119dc4b1da9631a2fed1f5977f91ce550374bdfb285807e144cd734c5a52b84

Request headers

Referer
https://ws.sharethis.com/button/css/buttons-secure.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 02 Oct 2020 18:53:22 GMT
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
server
nginx/1.16.1
age
662234
etag
"5f777241-34d"
x-cache
Hit from cloudfront
content-type
image/png
status
200
cache-control
max-age=31536000
x-amz-cf-pop
VIE50-C1
accept-ranges
bytes
x-robots-tag
noindex, nofollow
content-length
845
x-amz-cf-id
uXqMPl_6F0YklSKe-U4Ke2qyE6FOr8FurWTkcXOmvwlEURGVOwcfyg==
expires
Sat, 02 Oct 2021 18:53:22 GMT
linkedin_16.png
ws.sharethis.com/images/2017/ 		726 B
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ws.sharethis.com/images/2017/linkedin_16.png
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/css/buttons-secure.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
321b5c40cdc774049388e605a57292755af3187eab1f0a21a7b76c9a43f9e163

Request headers

Referer
https://ws.sharethis.com/button/css/buttons-secure.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 02 Oct 2020 18:53:22 GMT
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
server
nginx/1.16.1
age
662234
etag
"5f777241-2d6"
x-cache
Hit from cloudfront
content-type
image/png
status
200
cache-control
max-age=31536000
x-amz-cf-pop
VIE50-C1
accept-ranges
bytes
x-robots-tag
noindex, nofollow
content-length
726
x-amz-cf-id
w3vWo2jsPfbC-XNXtyfc0Z4qeSdn2K4N1B6OeHd1Wzqh-bh-JIF3rw==
expires
Sat, 02 Oct 2021 18:53:22 GMT
sharethis_16.png
ws.sharethis.com/images/2017/ 		777 B
1 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ws.sharethis.com/images/2017/sharethis_16.png
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/css/buttons-secure.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
df42ef61bf1c68494f00a152be5c470ee75736e1057851d1c329823e3a74aaae

Request headers

Referer
https://ws.sharethis.com/button/css/buttons-secure.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 02 Oct 2020 18:53:22 GMT
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
server
nginx/1.16.1
age
662234
etag
"5f763ff3-309"
x-cache
Hit from cloudfront
content-type
image/png
status
200
cache-control
max-age=31536000
x-amz-cf-pop
VIE50-C1
accept-ranges
bytes
x-robots-tag
noindex, nofollow
content-length
777
x-amz-cf-id
UZxGzmtnRlChYloSTjDBg1FAnZSHTCpYr9p0tmGhjklPInPeY9aADQ==
expires
Sat, 02 Oct 2021 18:53:22 GMT
pview
l.sharethis.com/ 		0
315 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://l.sharethis.com/pview?event=pview&version=buttons.js&lang=en&sessionID=1602327035891.74391&hostname=www.mdalert.com&location=%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&product=widget&fcmp=false&fcmpv2=false&publisher=f96e4750-7650-4314-8266-295613c9e1bf&bsamesite=true&consentDomain=.consensu.org&gdpr_domain=.consensu.org&gdpr_domain_v1=.consensu.org&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&title=FDA%20Grants%20Priority%20Review%20of%20Evinacumab%20BLA%20for%20High%20Cholesterol%20Condition%20-%20MDalert.com&sop=false&description=The%20FDA%20has%20granted%20priority%20review%20for%20a%20Biologics%20License%20Application%20for%20evinacumab%20as%20an%20adjunct%20treatment%20for%20patients%20with%20homozygous%20familial%20hypercholesteremia...&description=The%20FDA%20has%20granted%20priority%20review%20for%20a%20Biologics%20License%20Application%20for%20evinacumab%20as%20an%20adjunct%20treatment%20for%20patients%20with%20homozygous%20familial%20hypercholesteremia...&img_pview=true
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.43.194 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-195-43-194.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Sat, 10 Oct 2020 10:50:36 GMT
Access-Control-Max-Age
1728000
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
stid
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
Cookie set dest5.html
mdalert.demdex.net/ Frame 6B1E 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://mdalert.demdex.net/dest5.html?d_nsid=0
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.213.60.94 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-213-60-94.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Host
mdalert.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
demdex=82891840443463937234128117664307885371
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Thu, 08 Oct 2020 09:57:38 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Set-Cookie
demdex=82891840443463937234128117664307885371;Path=/;Domain=.demdex.net;Expires=Thu, 08-Apr-2021 10:50:36 GMT;Max-Age=15552000;Secure;SameSite=None
Strict-Transport-Security
max-age=31536000; includeSubDomains
Vary
Accept-Encoding, User-Agent
X-TID
sszVGoriRUs=
Content-Length
2785
Connection
keep-alive
id
mdalert.sc.omtrdc.net/ 		2 B
318 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://mdalert.sc.omtrdc.net/id?d_visid_ver=4.4.1&d_fieldgroup=A&mcorgid=46BC515C56B0B1DD7F000101%40AdobeOrg&mid=83232181709184631654161641652918130685&ts=1602327036179
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

status
200
date
Sat, 10 Oct 2020 10:50:35 GMT
x-content-type-options
nosniff
server
jag
xserver
anedge-58d4c4cffc-96zts
vary
Origin
x-c
master-1388.I1d56d5.M0-459
p3p
CP="This is not a P3P policy"
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, no-store, max-age=0, no-transform, private
access-control-allow-credentials
true
content-type
application/x-javascript;charset=utf-8
content-length
2
x-xss-protection
1; mode=block
ibs:dpid=411&dpuuid=X4GR-AAAB96m7BTJ
dpm.demdex.net/
Redirect Chain
  • https://cm.everesttech.net/cm/dd?d_uuid=82891840443463937234128117664307885371
  • https://dpm.demdex.net/ibs:dpid=411&dpuuid=X4GR-AAAB96m7BTJ
42 B
915 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://dpm.demdex.net/ibs:dpid=411&dpuuid=X4GR-AAAB96m7BTJ
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.242.67.216 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-242-67-216.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

DCS
dcs-prod-irl1-v083-02bd094ee.edge-irl1.demdex.com 5.78.1.20201008074624 1ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-Content-Type-Options
nosniff
X-TID
LRGOaiN1SoY=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Type
image/gif
Content-Length
42
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Date
Sat, 10 Oct 2020 10:50:36 GMT
Server
AMO-cookiemap/1.1
P3P
CP="NOI NID DEVa PSAa PSDa OUR IND PUR COM NAV INT DEM"
Location
https://dpm.demdex.net/ibs:dpid=411&dpuuid=X4GR-AAAB96m7BTJ
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=15,max=100
Content-Length
0
analytics.js
www.google-analytics.com/ 		45 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
60863e86aa7743d1ac841da7f473a05cd57fba81d661cef658e385437f80d5ef
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 09 Sep 2020 01:50:37 GMT
server
Golfe2
age
5697
date
Sat, 10 Oct 2020 09:15:39 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18650
expires
Sat, 10 Oct 2020 11:15:39 GMT
a.aspx
ads.jobson.com/ 		31 B
913 B 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.jobson.com/a.aspx?ZoneID=890&Task=Get&IFR=False&Browser=NETSCAPE4&PageID=39769&SiteID=4&Random=1602327036192&wd=1600
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3035::681b:8e4b , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
10e0e849504fd32c4bd9f9a10981cd2f0ed5fbe0810e22e01ddd86071e43a593

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Intervention
<https://www.chromestatus.com/feature/5718547946799104>; level="warning"

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"report_to":"cf-nel","max_age":604800}
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR NID ADMa OPTa OUR NOR"
status
200
cf-request-id
05b3bb593d0000d715debf9200000001
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?lkg-colo=71&lkg-time=1602327036"}],"group":"cf-nel","max_age":604800}
content-type
application/x-javascript; charset=utf-8
cache-control
private
delivered-by
intap01l-job-23
cf-ray
5dffc8086861d715-FRA
linkid.js
www.google-analytics.com/plugins/ua/ 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:49:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
age
67
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
859
x-xss-protection
0
expires
Sat, 10 Oct 2020 11:49:29 GMT
collect
www.google-analytics.com/j/ 		2 B
157 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j86&a=18944472&t=pageview&_s=1&dl=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&ul=en-us&de=UTF-8&dt=FDA%20Grants%20Priority%20Review%20of%20Evinacumab%20BLA%20for%20High%20Cholesterol%20Condition%20-%20MDalert.com&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aGBAAAAjAAAAAC~&jid=1605652199&gjid=602280955&cid=1257088673.1602327036&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&tid=UA-4869392-5&_gid=537213402.1602327036&_r=1&_slc=1&cd1=C787CF24DE0EE21AFA8D5BB76C36E25A&cd2=1023182227&z=1171681004
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a048e640908046be06e00eab37742b5d5ff80964af58cfd22f7cb2de4dfe375f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Sat, 10 Oct 2020 10:50:36 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
status
200
content-type
text/plain
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/ 		35 B
189 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google-analytics.com/collect?v=1&_v=j86&a=18944472&t=event&_s=2&dl=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&ul=en-us&de=UTF-8&dt=FDA%20Grants%20Priority%20Review%20of%20Evinacumab%20BLA%20for%20High%20Cholesterol%20Condition%20-%20MDalert.com&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&ec=TimeOnPage&ea=%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&el=10&_u=aGBAAAAjAAAAAC~&jid=&gjid=&cid=1257088673.1602327036&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&tid=UA-4869392-5&_gid=537213402.1602327036&cd1=C787CF24DE0EE21AFA8D5BB76C36E25A&cd2=1023182227&z=251616565
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 09 Oct 2020 23:25:14 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
41122
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
gpt.js
www.googletagservices.com/tag/js/ 		52 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: ads.ehealthcaresolutions.com
URL: https://ads.ehealthcaresolutions.com/jobson/?adid=jobson-mdalert-rc3&site=ehs.pro.jobson.mdalert&size=300x250,300x600,160x600&vpos=t&hpos=r&zone=hyperlipidemia&cat=&seg=&r=1805652023976116.5&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cbcda46ab25d2b82f466bea13bffd3a0f83fac19c5eee1950c76174cfd58df4e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"658 / 598 of 1000 / last-modified: 1602281443"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
17599
x-xss-protection
0
expires
Sat, 10 Oct 2020 10:50:36 GMT
pubads_impl_2020100601.js
securepubads.g.doubleclick.net/gpt/ 		271 KB
96 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
sffe /
Resource Hash
d30402b6c051753a27998a64e310201b9ffa7aa6688afb8ce936f349f257180e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 06 Oct 2020 08:39:42 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
97495
x-xss-protection
0
expires
Sat, 10 Oct 2020 10:50:36 GMT
s37783835465377
mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/ 		43 B
244 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/s37783835465377?AQB=1&ndh=1&pf=1&t=10%2F9%2F2020%2012%3A50%3A36%206%20-120&mid=83232181709184631654161641652918130685&aamlh=6&ce=UTF-8&ns=mdalert&pageName=article%3Afda-grants-priority-review-evinacumab&g=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_&cc=USD&ch=ms-hyperlipidemia&v0=Hyperlipidemia%3Aemail%3Aemail&events=event1%2Cevent14&aamb=6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y&v1=D%3Dc9&v2=D%3Dc8&c4=article&v5=D%3Dc7&v6=D%3Dg&c7=10%2F10%2F2020%2000%3A50%3A36%20PM&c8=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&c9=article%3Afda-grants-priority-review-evinacumab&c11=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&v11=C787CF24DE0EE21AFA8D5BB76C36E25A&v14=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&v17=ms-hyperlipidemia&v18=6226%3A17825149&v19=6226%3A917822&v29=1&v31=D%3Dc11&v32=D%3Dc11&v41=1023182227&v42=C787CF24DE0EE21AFA8D5BB76C36E25A&v43=1023182227&v46=D%3Dc7&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&-g=rid%3D6226%3A17825149&AQE=1
Requested by
Host: www.mdalert.com
URL: https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
a1ecbaed793a1f564c49c671f2dd0ce36f858534ef6d26b55783a06b884cc506
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
x-content-type-options
nosniff
x-c
master-1388.I1d56d5.M0-459
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sun, 11 Oct 2020 10:50:36 GMT
server
jag
xserver
anedge-58d4c4cffc-rvsz2
etag
3440971108643602432-4621515459719595860
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, no-transform, private
expires
Fri, 09 Oct 2020 10:50:36 GMT
integrator.js
adservice.google.de/adsid/ 		109 B
168 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.mdalert.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ 		109 B
246 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.mdalert.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/ 		444 B
283 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3147071814921052&correlator=1746704578860850&output=ldjh&impl=fif&eid=21065139%2C21066992%2C21067445%2C21067946&vrg=2020100601&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201010&iu_parts=6913%2Cehs.pro.jobson.mdalert%2Chyperlipidemia&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250%7C300x600%7C160x600&cust_params=r%3D1805652023976116_5%26class%3Dpro%26pub%3Djobson%26sn%3Dmdalert%26zn%3Dhyperlipidemia%26pgp%3Dms%252Chyperlipidemia%252Carticle%252Cfda-grants-priority-review-evinacumab%26pgq%3Dutm_content_microsite_link_utm_source_email_utm_medium_email_utm_campaign_Hyperlipidemia_uid_C787CF24DE0EE21AFA8D5BB76C36E25A_uid_npi_1023182227_wc_mid_6226_917822_wc_rid_6226_17825149%26ssl%3D1%26adid%3Djobson-mdalert-rc3%26vp%3Dt%26hp%3Dr&cookie_enabled=1&bc=31&abxe=1&lmt=1602327036&dt=1602327036573&dlt=1602327035530&idt=1019&frm=20&biw=1600&bih=1200&oid=3&adxs=1068&adys=622&adks=382676914&ucis=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&dssz=46&icsg=2251813756243964&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&ga_vid=1257088673.1602327036&ga_sid=1602327037&ga_hid=18944472&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfV0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
c71f337d51203cc6aaf75ea94b1a586b352c88141eabd689eaa704743973f7e9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
249
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
24783b95da8401f8f3739b9a78e012d7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://24783b95da8401f8f3739b9a78e012d7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
ads
securepubads.g.doubleclick.net/gampad/ 		443 B
282 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3147071814921052&correlator=1746704578860850&output=ldjh&impl=fif&eid=21065139%2C21066992%2C21067445%2C21067946&vrg=2020100601&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201010&iu_parts=6913%2Cehs.pro.jobson.mdalert%2Chyperlipidemia&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=728x90&cust_params=r%3D184954466426576_75%26class%3Dpro%26pub%3Djobson%26sn%3Dmdalert%26zn%3Dhyperlipidemia%26pgp%3Dms%252Chyperlipidemia%252Carticle%252Cfda-grants-priority-review-evinacumab%26pgq%3Dutm_content_microsite_link_utm_source_email_utm_medium_email_utm_campaign_Hyperlipidemia_uid_C787CF24DE0EE21AFA8D5BB76C36E25A_uid_npi_1023182227_wc_mid_6226_917822_wc_rid_6226_17825149%26ssl%3D1%26adid%3Djobson-mdalert-hd1%26vp%3Dt%26hp%3Dl&cookie_enabled=1&bc=31&abxe=1&lmt=1602327036&dt=1602327036585&dlt=1602327035530&idt=1019&frm=20&biw=1600&bih=1200&oid=3&adxs=230&adys=82&adks=1323048362&ucis=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&dssz=46&icsg=2251813756243964&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=847x90&msz=847x90&ga_vid=1257088673.1602327036&ga_sid=1602327037&ga_hid=18944472&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfV0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
a5fc794aa40d5d5248161e9c0025d1e3344d363e359cb852275a228eb359871a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
248
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		444 B
965 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3147071814921052&correlator=1746704578860850&output=ldjh&impl=fif&eid=21065139%2C21066992%2C21067445%2C21067946&vrg=2020100601&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201010&iu_parts=6913%2Cehs.pro.jobson.mdalert%2Chyperlipidemia&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250%7C300x600%7C160x600&cust_params=r%3D8166080233895827%26class%3Dpro%26pub%3Djobson%26sn%3Dmdalert%26zn%3Dhyperlipidemia%26pgp%3Dms%252Chyperlipidemia%252Carticle%252Cfda-grants-priority-review-evinacumab%26pgq%3Dutm_content_microsite_link_utm_source_email_utm_medium_email_utm_campaign_Hyperlipidemia_uid_C787CF24DE0EE21AFA8D5BB76C36E25A_uid_npi_1023182227_wc_mid_6226_917822_wc_rid_6226_17825149%26ssl%3D1%26adid%3Djobson-mdalert-rc2%26vp%3Dt%26hp%3Dr&cookie_enabled=1&bc=31&abxe=1&lmt=1602327036&dt=1602327036588&dlt=1602327035530&idt=1019&frm=20&biw=1600&bih=1200&oid=3&adxs=1068&adys=352&adks=1751027911&ucis=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&dssz=46&icsg=2251813756243964&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&ga_vid=1257088673.1602327036&ga_sid=1602327037&ga_hid=18944472&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfV0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
e8e10c841f64f35b5b512d6a4bdfc2d21d0e9420f6a28545fc740e6bd4508e21
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
250
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		444 B
284 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3147071814921052&correlator=1746704578860850&output=ldjh&impl=fif&eid=21065139%2C21066992%2C21067445%2C21067946&vrg=2020100601&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201010&iu_parts=6913%2Cehs.pro.jobson.mdalert%2Chyperlipidemia&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250%7C300x600%7C160x600&cust_params=r%3D895874397173206_4%26class%3Dpro%26pub%3Djobson%26sn%3Dmdalert%26zn%3Dhyperlipidemia%26pgp%3Dms%252Chyperlipidemia%252Carticle%252Cfda-grants-priority-review-evinacumab%26pgq%3Dutm_content_microsite_link_utm_source_email_utm_medium_email_utm_campaign_Hyperlipidemia_uid_C787CF24DE0EE21AFA8D5BB76C36E25A_uid_npi_1023182227_wc_mid_6226_917822_wc_rid_6226_17825149%26ssl%3D1%26adid%3Djobson-mdalert-rc4%26vp%3Dt%26hp%3Dr&cookie_enabled=1&bc=31&abxe=1&lmt=1602327036&dt=1602327036591&dlt=1602327035530&idt=1019&frm=20&biw=1600&bih=1200&oid=3&adxs=1068&adys=892&adks=271938303&ucis=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&dssz=46&icsg=2251813756243964&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&ga_vid=1257088673.1602327036&ga_sid=1602327037&ga_hid=18944472&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfV0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
3f4b81ff8afee457d9fcd2f0ee95157cd08d0ef70f17301267009ef1a2d19bdf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
251
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		444 B
280 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3147071814921052&correlator=1746704578860850&output=ldjh&impl=fif&eid=21065139%2C21066992%2C21067445%2C21067946&vrg=2020100601&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201010&iu_parts=6913%2Cehs.pro.jobson.mdalert%2Chyperlipidemia&enc_prev_ius=%2F0%2F1%2F2&prev_iu_szs=300x250%7C300x600%7C160x600&cust_params=r%3D2997895434716202_5%26class%3Dpro%26pub%3Djobson%26sn%3Dmdalert%26zn%3Dhyperlipidemia%26pgp%3Dms%252Chyperlipidemia%252Carticle%252Cfda-grants-priority-review-evinacumab%26pgq%3Dutm_content_microsite_link_utm_source_email_utm_medium_email_utm_campaign_Hyperlipidemia_uid_C787CF24DE0EE21AFA8D5BB76C36E25A_uid_npi_1023182227_wc_mid_6226_917822_wc_rid_6226_17825149%26ssl%3D1%26adid%3Djobson-mdalert-rc1%26vp%3Dt%26hp%3Dr&cookie_enabled=1&bc=31&abxe=1&lmt=1602327036&dt=1602327036595&dlt=1602327035530&idt=1019&frm=20&biw=1600&bih=1200&oid=3&adxs=1068&adys=82&adks=2980156183&ucis=5&ifi=5&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&dssz=46&icsg=2251813756243964&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&ga_vid=1257088673.1602327036&ga_sid=1602327037&ga_hid=18944472&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfV0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
27be491eabf24cc569a2313a9404aad35e273b23d228d913c409988760db6a95
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
250
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.mdalert.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
sodar
pagead2.googlesyndication.com/getconfig/ 		8 KB
7 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020100601&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
5b41d397553a63fab1e3f3b61be6122954b2e99d71656985636d032824a096ba
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6318
x-xss-protection
0
sodar2.js
tpc.googlesyndication.com/sodar/ 		17 KB
6 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020100601.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9ef0cc99ae155124895f712a9b68285f7b0a8c3f3c151e86107a25b61cf22085
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1601061966610483"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6293
x-xss-protection
0
expires
Sat, 10 Oct 2020 10:50:36 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/217/ Frame B785 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/217/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/217/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149

Response headers

status
200
accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
content-length
4867
date
Sat, 10 Oct 2020 08:38:00 GMT
expires
Sun, 10 Oct 2021 08:38:00 GMT
last-modified
Mon, 21 Sep 2020 23:28:38 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
7956
alt-svc
h3-Q050=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
gen_204
pagead2.googlesyndication.com/pagead/ 		0
223 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=217&t=2&li=gpt_2020100601&jk=3147071814921052&bg=!8POl89PNAAWqWepuqlgXQ0hqvSxDNgIAAABOUgAAAA4KAX0RGilK4V6B68Wo91vontdZWi2k_OHgLqZmo6nrShJHZUj5nS3ZKyQf3Va2kQCEvByzmpk9pheeligdunub_l05v3rkyG82KDAtILDvN2xRBLLFTD4j6i5Jlp0EqJefKlfuTntPpJMmHYxM2M8uT746-2n0--LsnAKlc9Vv8ASK6dTAj2OxVaY5eTerHMJpCc_jvl1roImn2-o316mW9XutkHamCbj2hn5lZ47dUH220LQ0A1tuDbnqo0unIiRq8gzHKtKbdH507jrU0XVELAeXNmUncAJR1pcaVzjtul9SkgjrFsJHErZ6LE2UVQ91Cd3ZhL32f1IjIYbMXxr8vN5rWo6msh5sMANM8GbZBK9-D9GtQCgk8wVZJAisUbLrImRDE4AiD7--CI5G4ULQ_pRHeohRukVwfbUDarc7ynpgE_t2ADHIGw0pY9H--zRrjf7JdTCpUdhOozW30AWlKYRo-tgFCKazVpBaEP7Ux3x8-ibVfvj58GFuTHc6P72ZAah1E-jATjIotuGynwFpI3tme8_D2_31W0BiuOVwbwKSA7z4M6h_8sr_cfWqztbWjCeeYfchdi1QxwHaLI-VvR7SczldNdvSDpDDKzDXB12vREc9kaxy6cOueoJL08PFri-LH8oGyOPCQoloNrgWcXjaIuDwBbstJy03_-QjGILbgFSmjNpBlS7yxJySjHltW15Nlgdftr7Js16K4xBiSe1Iu6_AaXNfZErnUEyPkTu5QMixmpYzNZ062W9LMbdHPZsuv6kQ3Ukoetc9GRC2VIgTyPLkWBGmOsh9wYbxozaZPCslAPTBeCuHdZzaMuzYoIYbTq5B2xw5i3Dl9NkbnAJ7KKUwd4GHsNJiGL7bCTgntiEAWmaWN-yp2QsVPq7vCdUi1s70aLn-yILiWlpSns_5wyMT6X_VPZtiKaKhoEljy8UkO03QUb_bH3f0JATpruuzx4rzNP-S1zoT4xql1ZdfZghZJxUETczypRXX15DSO5mSlCCUotBD5PnJ7NaMz7ihKnrbLaJXh1u-1kRQyc6igyp19nyKinSR6b8qLNc3mXTvFf9ZTA-x
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 10 Oct 2020 10:50:36 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.html
ws.sharethis.com/secure5x/ Frame 052C 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://ws.sharethis.com/secure5x/index.html
Requested by
Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/async-buttons.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206e:8c00:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash

Request headers

:method
GET
:authority
ws.sharethis.com
:scheme
https
:path
/secure5x/index.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149

Response headers

status
200
content-type
text/html
content-length
4080
content-encoding
gzip
date
Fri, 09 Oct 2020 20:35:36 GMT
etag
W/"5f80b36e-390f"
last-modified
Fri, 09 Oct 2020 19:01:02 GMT
server
nginx/1.16.1
x-robots-tag
noindex, nofollow
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
x-amz-cf-pop
VIE50-C1
x-amz-cf-id
wcR_LmDd1fiHzI7Y0lm6m9z6JgzyHcSq_Agx8SBIqLdtJFh0CYsptw==
age
51301
s34175800604290
mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/ 		43 B
209 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/s34175800604290?AQB=1&ndh=1&pf=1&t=10%2F9%2F2020%2012%3A50%3A38%206%20-120&mid=83232181709184631654161641652918130685&aamlh=6&ce=UTF-8&ns=mdalert&pageName=article%3Afda-grants-priority-review-evinacumab&g=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_&cc=USD&events=event34&v1=D%3Dc9&v2=D%3Dc8&c4=article&v5=D%3Dc7&c7=10%2F10%2F2020%2000%3A50%3A38%20PM&c8=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&c9=article%3Afda-grants-priority-review-evinacumab&c11=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&v11=C787CF24DE0EE21AFA8D5BB76C36E25A&v17=ms-hyperlipidemia&v23=2&v24=10%2F10%2F2020&v25=12&v26=00%3A50%3A37%20PM&v27=FALSE&v32=D%3Dc11&v41=1023182227&v42=C787CF24DE0EE21AFA8D5BB76C36E25A&v43=1023182227&pe=lnk_o&pev2=engagement%20seconds&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&-g=rid%3D6226%3A17825149&AQE=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
a1ecbaed793a1f564c49c671f2dd0ce36f858534ef6d26b55783a06b884cc506
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:37 GMT
x-content-type-options
nosniff
x-c
master-1388.I1d56d5.M0-459
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sun, 11 Oct 2020 10:50:38 GMT
server
jag
xserver
anedge-58d4c4cffc-bhbqz
etag
3440971112938569728-4621761757301957795
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, no-transform, private
expires
Fri, 09 Oct 2020 10:50:38 GMT
s34127521025218
mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/ 		43 B
209 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/s34127521025218?AQB=1&ndh=1&pf=1&t=10%2F9%2F2020%2012%3A50%3A41%206%20-120&mid=83232181709184631654161641652918130685&aamlh=6&ce=UTF-8&ns=mdalert&pageName=article%3Afda-grants-priority-review-evinacumab&g=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_&cc=USD&events=event34&v1=D%3Dc9&v2=D%3Dc8&c4=article&v5=D%3Dc7&c7=10%2F10%2F2020%2000%3A50%3A41%20PM&c8=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&c9=article%3Afda-grants-priority-review-evinacumab&c11=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&v11=C787CF24DE0EE21AFA8D5BB76C36E25A&v17=ms-hyperlipidemia&v23=5&v24=10%2F10%2F2020&v25=12&v26=00%3A50%3A40%20PM&v27=FALSE&v32=D%3Dc11&v41=1023182227&v42=C787CF24DE0EE21AFA8D5BB76C36E25A&v43=1023182227&pe=lnk_o&pev2=engagement%20seconds&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&-g=rid%3D6226%3A17825149&AQE=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
a1ecbaed793a1f564c49c671f2dd0ce36f858534ef6d26b55783a06b884cc506
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:40 GMT
x-content-type-options
nosniff
x-c
master-1388.I1d56d5.M0-459
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sun, 11 Oct 2020 10:50:41 GMT
server
jag
xserver
anedge-58d4c4cffc-gjd5f
etag
3440971119381020672-4621515288457795619
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, no-transform, private
expires
Fri, 09 Oct 2020 10:50:41 GMT
s33264081876812
mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/ 		43 B
209 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://mdalert.sc.omtrdc.net/b/ss/mdalertdotcomprod/1/JS-1.7.0-LAUN/s33264081876812?AQB=1&ndh=1&pf=1&t=10%2F9%2F2020%2012%3A50%3A46%206%20-120&mid=83232181709184631654161641652918130685&aamlh=6&ce=UTF-8&ns=mdalert&pageName=article%3Afda-grants-priority-review-evinacumab&g=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_&cc=USD&events=event34&v1=D%3Dc9&v2=D%3Dc8&c4=microsite&v5=D%3Dc7&c7=10%2F10%2F2020%2000%3A50%3A46%20PM&c8=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab&c9=microsite%3Ams-hyperlipidemia&c11=https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149&v11=C787CF24DE0EE21AFA8D5BB76C36E25A&v17=ms-hyperlipidemia&v23=10&v24=10%2F10%2F2020&v25=12&v26=00%3A50%3A45%20PM&v27=FALSE&v32=D%3Dc11&v41=1023182227&v42=C787CF24DE0EE21AFA8D5BB76C36E25A&v43=1023182227&pe=lnk_o&pev2=engagement%20seconds&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&-g=rid%3D6226%3A17825149&AQE=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
a1ecbaed793a1f564c49c671f2dd0ce36f858534ef6d26b55783a06b884cc506
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.mdalert.com/ms/hyperlipidemia/article/fda-grants-priority-review-evinacumab?utm_content=microsite_link&utm_source=email&utm_medium=email&utm_campaign=Hyperlipidemia&uid=C787CF24DE0EE21AFA8D5BB76C36E25A&uid_npi=1023182227&wc_mid=6226:917822&wc_rid=6226:17825149
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 10 Oct 2020 10:50:45 GMT
x-content-type-options
nosniff
x-c
master-1388.I1d56d5.M0-459
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sun, 11 Oct 2020 10:50:46 GMT
server
jag
xserver
anedge-58d4c4cffc-dxvz4
etag
3440971130118438912-4621620803992962868
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, no-transform, private
expires
Fri, 09 Oct 2020 10:50:46 GMT

Verdicts & Comments Add Verdict or Comment

112 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 function| showDirectoryPicker function| showOpenFilePicker function| showSaveFilePicker object| trustedTypes object| html5 object| Modernizr string| mduid string| uid_npi object| digitalData function| getCurrentDateTimeForEvent function| contentTimeSpentFive function| $ function| jQuery boolean| switchTo5x object| stlib function| _$d function| _$d0 function| _$d_ function| _$d1 function| _$d2 function| _$de function| _$dt object| _all_services boolean| tpcCookiesEnableCheckingDone boolean| tpcCookiesEnabledStatus string| customProduct string| stWidgetVersion object| stButtons object| stWidget boolean| sop_pview_logged object| ShareThisEvent object| stLight boolean| st_showing number| ehs_screenwidth object| respond function| getParameterByName function| URLEncode function| SearchOnEnter function| SearchOnEnterSidebar object| _satellite boolean| __satelliteLoaded object| adobe function| Visitor object| s_c_il number| s_c_in function| init_hash boolean| showHoverbarReskinned boolean| isEsiLoaded boolean| stShowNewMobileWidget boolean| isMobileButtonLoaded boolean| stRecentServices boolean| iswhatsappCustomButton boolean| isKikCustomButton boolean| stIsLoggedIn object| servicesLoggedIn object| stFastShareObj boolean| useFastShare object| stButtonsLib function| Shareable function| shareLog string| __stPubGA object| async_buttons function| foursquareCallback function| __stgetPubGA function| plusoneCallback boolean| openWidget function| s_doPlugins function| AppMeasurement_Module_ActivityMap function| AppMeasurement function| s_gi function| s_pgicq object| s number| s_objectID number| s_giq object| truste object| Handlebars function| getAbsoluteHeight string| GoogleAnalyticsObject function| ga string| browName number| SiteID number| ZoneID number| browDateTime number| wd object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| googletag boolean| ehs_config string| ehs_pgp object| dima1 object| ggeac object| google_js_reporting_queue string| adcode object| s_i_mdalertdotcomprod string| arg string| baseURL function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter undefined| google_measure_js_timing object| googleToken object| googleIMState function| processGoogleToken number| __google_ad_urls_id number| google_unique_id object| GoogleGcLKhOms object| google_image_requests string| messageSet

21 Cookies

Domain/Path Name / Value
.demdex.net/ Name: demdex
Value: 82891840443463937234128117664307885371
.mdalert.com/ Name: s_visit_start
Value: 1
.mdalert.com/ Name: s_cc
Value: true
.mdalert.com/ Name: gpv_p5
Value: article%3Afda-grants-priority-review-evinacumab
.mdalert.com/ Name: _mdA_engagement
Value: Yes
.mdalert.com/ Name: _microsite-href
Value: https%3A%2F%2Fwww.mdalert.com%2Fms%2Fhyperlipidemia%2Farticle%2Ffda-grants-priority-review-evinacumab%3Futm_content%3Dmicrosite_link%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3DHyperlipidemia%26uid%3DC787CF24DE0EE21AFA8D5BB76C36E25A%26uid_npi%3D1023182227%26wc_mid%3D6226%3A917822%26wc_rid%3D6226%3A17825149
.mdalert.com/ Name: AMCV_46BC515C56B0B1DD7F000101%40AdobeOrg
Value: 1075005958%7CMCIDTS%7C18546%7CMCMID%7C83232181709184631654161641652918130685%7CMCAAMLH-1602931836%7C6%7CMCAAMB-1602931836%7C6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y%7CMCOPTOUT-1602334236s%7CNONE%7CMCAID%7CNONE%7CMCSYNCSOP%7C411-18553%7CvVersion%7C4.4.1
.mdalert.com/ Name: _gat
Value: 1
www.mdalert.com/ Name: ASP.NET_SessionId
Value: lmjjkjv4b1r4qzmdtfhz4cuk
.mdalert.com/ Name: notice_behavior
Value: none
www.mdalert.com/ Name: BIGipServerjhi-pharm-job-23.portal.webmd.com-80
Value: 4244643082.20480.0000
.mdalert.com/ Name: s_engagement_start
Value: 1
.mdalert.com/ Name: _ga
Value: GA1.2.1257088673.1602327036
.mdalert.com/ Name: _microsite-time
Value: 1602327036452
www.mdalert.com/ Name: mduid
Value: C787CF24DE0EE21AFA8D5BB76C36E25A
www.mdalert.com/ Name: uid_npi
Value: 1023182227
www.mdalert.com/ Name: mda_hyperlipidemia_seg
Value:
.mdalert.com/ Name: _gid
Value: GA1.2.537213402.1602327036
.mdalert.com/ Name: _microsite
Value: ms-hyperlipidemia
.mdalert.com/ Name: AMCVS_46BC515C56B0B1DD7F000101%40AdobeOrg
Value: 1
.mdalert.com/ Name: __cfduid
Value: d9513a5e0deea2362a1ab54715c10f45b1602327035

1 Console Messages

Source Level URL
Text
console-api log URL: https://assets.adobedtm.com/4928ad52470e/46c35e8b30ec/launch-4f529be4e422.min.js(Line 5)
Message:
Launch: primaryCategory is ms-hyperlipidemia

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

24783b95da8401f8f3739b9a78e012d7.safeframe.googlesyndication.com
ads.ehealthcaresolutions.com
ads.jobson.com
adservice.google.com
adservice.google.de
assets.adobedtm.com
c.sharethis.mgr.consensu.org
cm.everesttech.net
consent.trustarc.com
dpm.demdex.net
emsg.alertmarketingmail.com
fonts.googleapis.com
fonts.gstatic.com
l.sharethis.com
mdalert.demdex.net
mdalert.sc.omtrdc.net
pagead2.googlesyndication.com
securepubads.g.doubleclick.net
tpc.googlesyndication.com
ws.sharethis.com
www.google-analytics.com
www.googletagservices.com
www.mdalert.com
15.236.9.100
172.217.22.98
18.195.43.194
2600:9000:206e:8c00:3:c04e:c780:93a1
2600:9000:2127:b800:c:a9b7:ddc0:93a1
2606:4700:3032::681b:9282
2606:4700:3035::681b:8e4b
2a00:1450:4001:806::2001
2a00:1450:4001:808::2002
2a00:1450:4001:816::2003
2a00:1450:4001:819::200e
2a00:1450:4001:81a::2002
2a00:1450:4001:824::2001
2a00:1450:4001:824::200a
2a02:26f0:eb:391::1e80
34.210.132.119
34.242.67.216
52.213.60.94
54.86.143.179
65.9.96.7
66.117.28.86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